These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 27989745)

  • 1. Interaction of different statins with model membranes by NMR data.
    Galiullina LF; Aganova OV; Latfullin IA; Musabirova GS; Aganov AV; Klochkov VV
    Biochim Biophys Acta Biomembr; 2017 Mar; 1859(3):295-300. PubMed ID: 27989745
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction of statins with phospholipid bilayers studied by solid-state NMR spectroscopy.
    Galiullina LF; Scheidt HA; Huster D; Aganov A; Klochkov V
    Biochim Biophys Acta Biomembr; 2019 Mar; 1861(3):584-593. PubMed ID: 30578770
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacodynamics and pharmacokinetics of the HMG-CoA reductase inhibitors. Similarities and differences.
    Lennernäs H; Fager G
    Clin Pharmacokinet; 1997 May; 32(5):403-25. PubMed ID: 9160173
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nitric oxide (NO)-releasing statin derivatives, a class of drugs showing enhanced antiproliferative and antiinflammatory properties.
    Ongini E; Impagnatiello F; Bonazzi A; Guzzetta M; Govoni M; Monopoli A; Del Soldato P; Ignarro LJ
    Proc Natl Acad Sci U S A; 2004 Jun; 101(22):8497-502. PubMed ID: 15173604
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Binding thermodynamics of statins to HMG-CoA reductase.
    Carbonell T; Freire E
    Biochemistry; 2005 Sep; 44(35):11741-8. PubMed ID: 16128575
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low-density lipoprotein cholesterol (LDL-C) levels and LDL-C goal attainment among elderly patients treated with rosuvastatin compared with other statins in routine clinical practice.
    Harley CR; Gandhi S; Blasetto J; Heien H; Sasane R; Nelson SP
    Am J Geriatr Pharmacother; 2007 Sep; 5(3):185-94. PubMed ID: 17996658
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A literature search on pharmacokinetic drug interactions of statins and analysis of how such interactions are reflected in package inserts in Japan.
    Saito M; Hirata-Koizumi M; Urano T; Miyake S; Hasegawa R
    J Clin Pharm Ther; 2005 Feb; 30(1):21-37. PubMed ID: 15659001
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An economic analysis of the Atorvastatin Comparative Cholesterol Efficacy and Safety Study (ACCESS).
    Smith DG; McBurney CR
    Pharmacoeconomics; 2003; 21 Suppl 1():13-23. PubMed ID: 12648031
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A cost-effectiveness model of alternative statins to achieve target LDL-cholesterol levels.
    Maclaine GD; Patel H
    Int J Clin Pract; 2001 May; 55(4):243-9. PubMed ID: 11406909
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of interactions of simvastatin, pravastatin, fluvastatin, and pitavastatin with bovine serum albumin: multiple spectroscopic and molecular docking.
    Shi JH; Wang Q; Pan DQ; Liu TT; Jiang M
    J Biomol Struct Dyn; 2017 May; 35(7):1529-1546. PubMed ID: 27484332
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biosynthesis and biotechnological production of statins by filamentous fungi and application of these cholesterol-lowering drugs.
    Manzoni M; Rollini M
    Appl Microbiol Biotechnol; 2002 Apr; 58(5):555-64. PubMed ID: 11956737
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of potentially severe drug-drug interactions in ambulatory patients with dyslipidaemia receiving HMG-CoA reductase inhibitor therapy.
    Rätz Bravo AE; Tchambaz L; Krähenbühl-Melcher A; Hess L; Schlienger RG; Krähenbühl S
    Drug Saf; 2005; 28(3):263-75. PubMed ID: 15733030
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-lipid-related effects of statins.
    Bellosta S; Ferri N; Bernini F; Paoletti R; Corsini A
    Ann Med; 2000 Apr; 32(3):164-76. PubMed ID: 10821323
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative evaluation of the safety and efficacy of HMG-CoA reductase inhibitor monotherapy in the treatment of primary hypercholesterolemia.
    Hsu I; Spinler SA; Johnson NE
    Ann Pharmacother; 1995; 29(7-8):743-59. PubMed ID: 8520093
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost-effectiveness analysis of cholesterol-lowering therapies in Spain.
    Plans-Rubió P
    Am J Cardiovasc Drugs; 2006; 6(3):177-88. PubMed ID: 16780391
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pleiotropic effects of statins in atherosclerosis and diabetes.
    Bellosta S; Ferri N; Arnaboldi L; Bernini F; Paoletti R; Corsini A
    Diabetes Care; 2000 Apr; 23 Suppl 2():B72-8. PubMed ID: 10860194
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Simvastatin Sodium Salt and Fluvastatin Interact with Human Gap Junction Gamma-3 Protein.
    Marsh A; Casey-Green K; Probert F; Withall D; Mitchell DA; Dilly SJ; James S; Dimitri W; Ladwa SR; Taylor PC; Singer DR
    PLoS One; 2016; 11(2):e0148266. PubMed ID: 26863535
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipophilic statins suppress cytotoxicity by freshly isolated natural killer cells through modulation of granule exocytosis.
    Tanaka T; Porter CM; Horvath-Arcidiacono JA; Bloom ET
    Int Immunol; 2007 Feb; 19(2):163-73. PubMed ID: 17182966
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A model to assess the cost effectiveness of statins in achieving the UK National Service Framework target cholesterol levels.
    Wilson K; Marriott J; Fuller S; Lacey L; Gillen D
    Pharmacoeconomics; 2003; 21 Suppl 1():1-11. PubMed ID: 12648030
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure of pravastatin and its complex with sodium dodecyl sulfate micelles studied by NMR spectroscopy.
    Galiullina LF; Rakhmatullin IZ; Klochkova EA; Aganov AV; Klochkov VV
    Magn Reson Chem; 2015 Feb; 53(2):110-4. PubMed ID: 25264019
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.